phase readout
saveNCT02158091: A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia
view source ↗
comments(0)
5-min edit window · permanent after that